KURA ONCOLOGY, INC. Property, Plant and Equipment
KURA ONCOLOGY, INC. (KURA) had Property, Plant and Equipment of $7.59 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-12
- 2026-06-30: Property, Plant and Equipment, Net $7.59M.
- 2026-03-31: Property, Plant and Equipment, Net $7.61M.
- 2025-12-31: Property, Plant and Equipment, Net $7.86M.
- 2025-09-30: Property, Plant and Equipment, Net $7.40M.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2026-06-30 | $7.59M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $7.61M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $7.86M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $7.40M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $3.91M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.35M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $1.68M 10-K · filed 2026-03-05 |
| 2024-09-30 | $1.31M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.52M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.71M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.86M 10-K · filed 2025-02-28 |
| 2023-09-30 | $2.06M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.25M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.37M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $2.54M 10-K · filed 2024-02-27 |
| 2022-09-30 | $2.73M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $2.55M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $2.57M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $2.67M 10-K · filed 2023-02-23 |
| 2021-09-30 | $2.73M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $2.30M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.07M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.02M 10-K · filed 2022-02-24 |
| 2020-09-30 | $2.10M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.65M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $805.00K 10-Q · filed 2020-05-04 |
| 2019-12-31 | $44.00K 10-K · filed 2021-02-24 |
| 2018-06-30 | $1.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | $5.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $10.00K 10-K · filed 2019-03-05 |
| 2017-09-30 | $17.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $24.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | $32.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $40.00K 10-K · filed 2018-03-12 |
| 2016-09-30 | $47.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $55.00K 10-Q · filed 2016-08-10 |
| 2016-03-31 | $62.00K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $71.00K 10-K · filed 2017-03-14 |
| 2015-09-30 | $78.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $59.00K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $34.00K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $27.00K 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |